One of our core principles is innovating medical technology in the field of cardiology
Setting the Pace, Pioneering the Future
One of our core principles is innovating medical technology in the field of cardiology. Since our founder Max Schaldach developed the first German pacemaker in 1963, we have paved the way for pioneering innovations.
BIOTRONIK places utmost importance on research and development in order to continuously improve the diagnosis, treatment and prevention of cardiovascular and endovascular disease. In our Berlin headquarters alone, one out of every five employees work in R&D, ensuring that medical technology keeps pace with the interests and needs of future patients and physicians.
Cardiac Rhythm Management
Our pacemakers, implantable defibrillators and remote monitoring technologies offer solutions of the highest quality to people suffering from cardiac arrhythmias.
BIOTRONIK Home Monitoring – Reliable Telemedicine
We were the first to combine medical technology with telecommunication to enable the automatic, daily transfer of patients’ clinical and device data to their physician. Our technology remains the most reliable, effective and convenient remote monitoring system on the market. Millions of patients, physicians and clinics worldwide rely on Home Monitoring.
Closed Loop Simulation for Pacemakers and ICDs
The most advanced system to regulate cardiac activity; Closed Loop Stimulation is used in our pacemakers and ICDs. It reacts to patients’ physical and mental state. This one-of-a-kind system optimizes patients’ heartbeats based on neurological information, allowing the device to react to mental activity or stress.
ProMRI – Safe MRI Scans for Cardiac Device Patients
With ProMRI technology, BIOTRONIK enables patients with cardiac rhythm management implants to safely undergo MRI scans. We offer the world’s largest portfolio of pacemakers, defibrillators and leads approved to undergo MRIs.
DX Atrial Sensing for Patients with Atrial Fibrillation
The DX system is the world’s only single-chamber defibrillator that can detect atrial fibrillation. Using only a single lead, the system can precisely detect rhythm disturbances in the heart’s ventricle and atrium. The DX system broadens the therapy options available to patients while increasing their safety.
Fractal Coating – Innovation for Leads
We first developed fractal coating in the 1990s and continue to perfect it. Fractal coating optimizes leads’ electrical surface, thereby maximizing their sensing and pacing capabilities. BIOTRONIK remains the only manufacturer of these unique leads.
Our heart catheters offer reliable solutions to diagnose and treat cardiac arrhythmias.
AlCath Flux eXTRA Gold – A New Ablation Catheter
With its unique pure gold tip, this ablation catheter offers thermal conductivity up to four times greater than conventional catheters. Its three-dimensional profile ensures optimal distribution and superior cooling. AlCath Flux eXTRA Gold is one of the most effective and safe therapies for patients with atrial fibrillation.
We develop stents, scaffolds, balloon catheters and guide wires for the effective treatment of coronary and peripheral artery disease.
Magmaris® – The First Clinically Proven Resorbable Magnesium Scaffold
Magmaris is the first resorbable magnesium scaffold on the market indicated for the treatment of de novo coronary artery lesions.1 The device provides novel benefits that only a magnesium scaffold can offer like fast resorption, compelling safety data2 and better deliverability.
1 Indication as per IFU
2 Based on BIOSOLVE-II, -II/-III and -IV, for patient populations see study details
Orsiro® – A Milestone in Stent Technology
With Orsiro, BIOTRONIK offers the world’s first hybrid drug-eluting stent with a bioabsorbable coating. Its unique design and exceptional deliverability mark a new era in the treatment of constricted coronary vessels. The stent is precise, even when used in difficult vessel anatomies. A passive proBIO coating encapsulates the stent and minimizes interaction with the surrounding tissue. BIOlute active coating combines a drug with a special bioabsorbable polymer matrix, ensuring a controlled drug-release.
PK Papyrus® – Designed to Save Lives When Seconds Count
This covered coronary stent made of cobalt chromium alloy treats acute coronary artery perforations. Thanks to its ultrathin*-strut design, the stent offers excellent flexibility and exceptional deliverability, even in difficult vessel anatomies.
* ø 2.25 – 3.0 mm.
Pulsar®-18 – A Pioneer in 4 F Stent Technology
With its 4 F system, BIOTRONIK set new standards in the minimally invasive treatment of blood vessels with stents. The low rate of major complications at the puncture site helps make Pulsar-18 one of the most successful long-term therapies.
Passeo®-18 Lux® – Long-Term Protection
Passeo-18 Lux is a novel combination of a balloon catheter and drug for the treatment of new and recurring narrowed blood vessels in the lower limbs. Proven Lux coating technology leads to long-term therapy success, protecting users and the balloon’s coating from contact and damage.